Fluvoxamine, melatonin and COVID-19
Psychopharmacology (Berl)
.
2021 Feb;238(2):611.
doi: 10.1007/s00213-020-05753-z.
Epub 2021 Jan 4.
Author
George M Anderson
1
Affiliation
1
Child Study Center and the Department of Laboratory Medicine, Yale University School of Medicine, 230 S. Frontage Rd., New Haven, CT, 06525, USA. george.anderson@yale.edu.
PMID:
33392622
PMCID:
PMC7779245
DOI:
10.1007/s00213-020-05753-z
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Clinical Deterioration*
Fluvoxamine
Humans
Melatonin*
Outpatients
SARS-CoV-2
Substances
Melatonin
Fluvoxamine